Likewise, a meta-analysis evaluating the association between FGF23 and cardiovascular outcomes found no significant exposure-response relationship in patients with and without chronic kidney disease (CKD) (Marthi et al., 2018). This evidence concerns the gene FGF23 and chronic kidney disease.